Gautam Patel, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 189,812 shares at $8.02 ($1.5M) on 2025-06-16, disclosed to the SEC on 2025-06-18.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.02 | 94,906 | $761K | 50.0% |
| 2 | $8.02 | 94,906 | $761K | 50.0% |
| Total | $8.02 avg | 189,812 | $1.5M | 100% |
| Filing → |
| AMRX | SELL | 2025-04-02 | $664K | — | Filing → |
| AMRX | SELL | 2025-03-05 | $712K | — | Filing → |
| AMRX | SELL | 2025-02-05 | $651K | — | Filing → |